Abstract
Daclatasvir (Daklinza) plus sofosbuvir (Sovaldi) is the first all-oral, interferon- and ribavirin-free drug regimen for treatment of hepatitis C virus genotype 3 infection. This combination is effective and convenient, but it is very expensive.
MeSH terms
-
Animals
-
Antiviral Agents / administration & dosage*
-
Carbamates
-
Clinical Trials as Topic / methods
-
Drug Therapy, Combination
-
Genotype*
-
Hepacivirus / drug effects*
-
Hepatitis C / diagnosis
-
Hepatitis C / drug therapy*
-
Humans
-
Imidazoles / administration & dosage*
-
Pyrrolidines
-
Sofosbuvir / administration & dosage*
-
Valine / analogs & derivatives
Substances
-
Antiviral Agents
-
Carbamates
-
Imidazoles
-
Pyrrolidines
-
Valine
-
daclatasvir
-
Sofosbuvir